Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs linked to growth hormones may increase the chance of hair loss in women.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

PRGF treatment safely and effectively helps hair loss.

Clascoterone may be an effective topical treatment for hair loss.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Neuropeptides affect hair growth and could be used to control it.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Both treatments for alopecia areata are equally effective and safe.

Potassium channel openers like minoxidil boost hair growth.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Ethanol-induced motor incoordination in rats is not affected by increased neuroactive steroids.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Glibenclamide slows breast cancer cell growth by stopping cell division.

A new compound shows promise as a topical treatment for hair loss.

GnRH treatment can reduce breast cancer cell invasion.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.